Indonesia Tissue Paper Manufacturing Company: PT PMA, Factory Licences, Site, and Cost

The practical answer: a foreign-owned tissue factory can generally be established as an Indonesian PT PMA, but “tissue manufacturing” must first be divided into the correct production model. A plant making or converting paper tissue belongs on the non-textile branch of KBLI 17091. For a large enterprise, the current OSS display classifies that branch as high risk and shows an Izin , not merely an NIB, as the business-licensing output. The same five-digit KBLI also contains a separate textile absorbent-goods branch whose large-enterprise output is a verified Standard Certificate. Treating those branches as interchangeable can produce the wrong licence, site study, environmental document, and budget.

The investment decision should therefore start with a signed product-and-process schedule: inputs, machinery, utilities, annual capacity, finished stock-keeping units, skin-contact claims, packaging, and waste streams. That schedule drives the KBLI scope, OSS risk row, industrial site, environmental screening, building approvals, product-specific permissions, and commissioning evidence. An NIB created before those facts are stable is an identifier, not proof that a factory is ready to run.

Key takeaways

• Scope is the first gate. KBLI 17091 covers paper tissue and listed household or sanitary paper goods, including facial, kitchen, napkin, towel, and toilet tissue; it is not a general pulp, packaging, or printing code.
• The large-enterprise output depends on the OSS scope row. The core non-textile paper-tissue branch is high risk with an Izin; the textile absorbent-goods branch is medium-high risk with a Standard Certificate.
• PT PMA figures are separate. Planned investment generally exceeds IDR 10 billion excluding land and buildings per applicable five-digit KBLI and project location, while minimum issued and paid-up capital is IDR 2.5 billion per company.
• Site choice changes the licence file. Integrated tissue making requires materially different water, energy, wastewater, emission, and utility studies from dry converting of purchased parent rolls.
• Budget in layers. Incorporation fees, statutory investment and capital, site and building work, environmental and product compliance, equipment, and working capital are different cash decisions.

Define the KBLI 17091 manufacturing boundary

The current starting point is KBLI 2025 code 17091, Industri Kertas Tisu . The official description covers manufacture of household paper and cellulose-wadding goods and expressly lists cleaning tissue, facial tissue, kitchen tissue, lens-cleaning tissue, paper handkerchiefs, paper towels, paper napkins, toilet tissue, cup or tray napkins, cotton paper, cigarette paper, and specified sanitary absorbent goods. The official OSS KBLI 17091 record is the live source to check against the planned product sheet.

In operational terms, the code can cover two common paper-tissue models. An integrated mill prepares fibre stock and forms, presses, dries, reels, and may convert tissue paper. A converting plant buys tissue jumbo or parent rolls and rewinds, embosses, laminates, perforates, folds, cuts, wraps, and packs finished toilet rolls, facial tissues, towels, or napkins. Both can produce listed tissue goods, but their environmental and utility profiles are not remotely equivalent. The business description in the deed, NIB, environmental application, building design, machine list, and industry data should all describe the same selected model.

KBLI 2025 also splits 17091 into two OSS scopes. One is for diapers, sanitary napkins, tampons, and related absorbent articles made from textile material. The other covers the paper-tissue activity and the listed products other than that textile-material subset. This split matters even if both scopes share the same five-digit number, because the risk rating and licensing output differ. A project producing both paper tissue and textile-based hygiene goods should map each line and obtain OSS treatment for each relevant scope rather than placing every SKU under a single generic “tissue” label.

The 2025 classification did not erase the older code history. The official conversion table maps KBLI 2020 code 17091 to KBLI 2025 code 17091, while the reverse table also shows that part of the textile-apparel classification moved into the new textile absorbent scope. Existing corporate records created under KBLI 2020 therefore need a product-level migration check; numerical continuity alone does not establish that the selected 2025 scope is correct. The prior official KBLI 2020 description is useful for that reconciliation.

Several boundaries should be written into the project memo. Pulp production is upstream and requires a different activity analysis; see the separate pulp-mill approval path . General printing and writing paper, corrugated packaging, paperboard containers, commercial printing, and unrelated paper articles are not brought into 17091 merely because paper is an input. Warehousing or wholesale of imported finished tissue also is not manufacturing. When a factory prints branded wrappers, the team should determine whether that is an incidental in-line step or a separate commercial printing activity.

A defensible scope pack contains a process flow, raw-material bill, machine schedule, rated annual capacity, product photographs or specifications, material composition by SKU, intended-use and skin-contact statements, waste map, and a site layout. It should distinguish paper from textile or nonwoven absorbent components. That evidence makes the OSS row selection auditable and prevents later contradictions between corporate documents, environmental approvals, customs facilities, industrial reporting, and product registrations.

Set the PT PMA ownership and capital structure

A foreign investor normally establishes a limited liability company with foreign investment status, a PT PMA. Indonesia’s investment-list framework opens business fields unless they are closed, reserved to the central government, or subject to stated conditions. No foreign-equity cap specific to KBLI 17091 is identified in the current investment-list annexes, so a tissue-manufacturing PT PMA is generally capable of full foreign ownership. That conclusion should still be checked against every additional KBLI and any special product activity placed in the same company. The controlling general rule appears in Presidential Regulation 49 of 2021 .

The company is a large enterprise by virtue of its PMA status. Under the current investment licensing procedure, the general planned-investment threshold is more than IDR 10 billion, excluding land and buildings, per five-digit KBLI per project location. Manufacturing receives a production-line formulation: variants or types of goods produced through one production line may be assessed together for the threshold. This is not permission to count an unrelated second line or another location in the same amount. The application should show machinery, pre-operating expenditure, and other qualifying investment in a traceable project budget.

Issued and paid-up capital is a different number. The current minimum is IDR 2.5 billion per limited company. It is balance-sheet equity contributed to the company, not a government fee and not the same as the investment-plan threshold. Current rules also restrict moving that capital out of the company’s account for at least twelve months, except for asset purchases, construction, or company operations. The operative figures and permitted use are stated in the 2025 BKPM licensing procedure .

The deed should align shareholder percentages, directors and commissioners, registered office, business purposes, KBLI codes, authorised capital, issued capital, and paid-up capital. A factory address should not be invented before the site is defensible. Where incorporation must precede the final lease, the company can use a legally acceptable corporate address while treating the factory location as a controlled later OSS change; it must not present a virtual office as the operating premises for an industrial plant. Beneficial-owner reporting, tax registration, corporate bank onboarding, employment planning, and immigration for foreign personnel belong in the same mobilisation plan.

For a group with multiple Indonesian projects, one PT PMA is not automatically the best container. A standalone factory entity can isolate environmental and operational liabilities and make project finance clearer, but adds governance and compliance cost. A multi-activity entity can share functions, but its capital, licences, premises, reporting, and transfer-pricing records become more complex. Decide this before deed execution, because post-formation changes ripple through OSS, tax, bank, customs, land, and contracting records.

Match the factory to the current OSS risk output

For a large enterprise selecting the non-textile paper-tissue scope of KBLI 17091, the current OSS record shows high risk and the licensing type Izin . The commercial operating position is therefore NIB plus the verified Izin and all linked basic and sectoral requirements. An NIB by itself does not replace the Izin. The current legal definition likewise describes an Izin as government approval that must be fulfilled before the business activity is carried out. Both the risk row and output should be captured from the current OSS activity page when the project application is prepared.

For the separate textile-material absorbent-goods scope, the large-enterprise row is medium-high risk and shows a Standard Certificate . That certificate must be verified; a self-declared, unverified state is not the end point for medium-high-risk operations. This distinction is especially important for a mixed facility making toilet tissue on one line and textile or nonwoven diapers or sanitary products on another. The company may need two scope-specific fulfilment tracks even though the headline KBLI number is identical.

The Izin requirements displayed for the paper-tissue branch turn the project description into evidence. They include plans for raw materials, energy and water; machine and equipment documentation; organisational information; a production flow diagram; accident-prevention facilities; and product specifications and intended use. For specified sanitary goods and tissue applied to human skin, OSS displays additional responsible-technical-person and good-manufacturing-practice commitments. The team should treat these as design inputs, not documents to fabricate after installation.

Risk-based business licensing sits on top of basic requirements. These normally include spatial conformity, environmental approval, and building approvals as applicable. The NIB identifies the business and can perform other administrative functions, but it does not prove those project-specific gates are complete. The national framework is now Government Regulation 28 of 2025; its official status and text are available through the BKPM legal-information portal .

A useful licence register records, for every output, the issuing authority, OSS project ID, location, five-digit KBLI, scope code, risk level, scale, document status, verification status, prerequisites, expiry or surveillance obligation, and responsible owner. Save the current OSS screen or generated document in the controlled file. Risk displays and nomenclature can change with implementing rules, so the stored evidence matters when a lender, customer, auditor, or inspector asks why the factory started production.

Choose a site that can support the process

Site selection should follow the process model, not precede it. Indonesian industrial-location rules generally direct industrial companies to industrial estates, subject to the limited exceptions in the applicable spatial and industrial framework. For a new PMA factory, a functioning industrial estate is usually the most defensible baseline because spatial designation, heavy-vehicle access, utilities, emergency services, and estate environmental infrastructure can be assessed together. Government Regulation 20 of 2024 is the current industrial-zoning framework; its official record is available from the national legislation database .

Do not sign an unconditional lease after seeing only a zoning brochure. Obtain evidence of land or building rights, permitted industrial uses, plot parameters, spatial conformity or KKPR route, estate regulations, access, fire-water and emergency capacity, electricity quality and available megavolt-amperes, gas or steam options, process-water quantity and quality, wastewater acceptance limits, storm-water segregation, waste storage rights, telecoms, truck circulation, and expansion space. Confirm whether existing PBG and SLF documents match the intended building use and floor area. A landlord’s licence is not the tenant manufacturer’s business licence.

An integrated tissue machine has a demanding utility profile. Stock preparation and sheet formation require reliable water; drying can require substantial steam and energy; vacuum systems, refiners, pumps, and compressed air affect load and noise; boilers or other combustion sources affect air-emission controls; process effluent requires a characterised flow and treatment route. Fibre recovery, broke handling, chemical storage, sludge, and wastewater variability must be designed before the environmental application. A site without a legally and technically workable discharge route is not made viable by a cheaper rent.

A dry converter of purchased parent rolls may avoid pulping and wet sheet formation, but it is not impact-free. Rewinding, embossing, folding, cutting, core making, gluing, printing, and packing create paper dust, trim, noise, fire load, adhesive or ink containers, packaging waste, and occupational-safety risks. Dust extraction, housekeeping, earthing, machine guarding, fire compartmentation, and bale or trim storage should appear in the layout. If lotions, fragrances, wetting solutions, or printing processes are added, emissions, wastewater, chemicals, and product-use assessments can change.

The environmental instrument must be screened against the actual capacity, process, location, land area, water abstraction, discharges, emissions, and sensitive receptors. Depending on that screening, the project may require an AMDAL, UKL-UPL, or another applicable route; it should not select a lighter document from the company size alone. Government Regulation 22 of 2021 provides the environmental-protection framework, including environmental approvals and technical treatment of emissions, wastewater, and waste. The current official text can be checked in the environmental regulation record .

Map every water and waste stream. Identify the water source and entitlement; domestic and process wastewater; cooling, boiler blowdown, and cleaning flows; roof and yard drainage; air-emission sources; noise; paper broke and trim; wastewater sludge; used oils; chemical or ink residues; contaminated containers; and laboratory waste. Determine which streams are recyclable, which are accepted by the estate, and which require licensed transport and treatment. Technical approvals or operational feasibility documents may be required for wastewater discharge, utilisation, or air emissions, while hazardous waste needs compliant identification, storage, records, handover, and emergency controls.

Make the lease conditional on a written red-flag report. The go-ahead conditions should include spatial compatibility, environmental route feasibility, sufficient utility reservations, estate consent to the precise process, fire and building feasibility, and no unresolved discharge or waste pathway. If the integrated line depends on a future estate wastewater upgrade or unallocated water volume, price and schedule are not yet bankable.

Build the factory and product licence stack

The factory file has several layers. Corporate formation establishes the PT PMA and its governance. OSS issues the NIB and presents the risk-based business output. Basic requirements deal with location, environment, and buildings. Sectoral evidence supports verification of the Izin or Standard Certificate. Product or supporting business licences, often displayed as PB UMKU options, apply only when the actual product and intended use trigger them. Customs, manpower, immigration, tax, and local operational requirements form separate workstreams.

PBG and SLF are not interchangeable. PBG approves construction, alteration, expansion, reduction, or maintenance against building standards; SLF confirms that the completed building is fit for use. For a leased shell, review the owner’s existing documents against the new occupancy, loading, fire protection, mezzanines, boilers, tanks, stacks, wastewater plant, machinery foundations, and extensions. A material alteration can require a building approval change before work begins. The applicable national implementing framework is Government Regulation 16 of 2021 .

Product requirements must be screened SKU by SKU. The OSS page lists possible supporting permissions connected with standards, household-health supplies, health-device distribution, good-manufacturing-practice evidence, and other uses. That list is a menu of potentially relevant outputs, not a declaration that every toilet roll or napkin needs every item. Tissue applied to human skin, sanitary absorbent products, baby or adult products, medical claims, food-contact use, tobacco-paper use, and ordinary cleaning tissue can follow different product regimes. Do not place a medical, disinfecting, antibacterial, hypoallergenic, flushable, food-safe, or halal claim on the product schedule without identifying its evidentiary and regulatory consequence.

SNI treatment is also product-specific. A published Indonesian standard does not automatically mean mandatory certification. The manufacturer must determine whether a current ministerial instrument makes a particular SNI compulsory for the precise product, whether a buyer requires voluntary certification, and whether testing and factory assessment can be completed. Where the selected OSS row requires ISO 9001, calibration, laboratory testing, a responsible technical person, or good-manufacturing-practice commitments, include those items in the commissioning budget and organisation chart rather than treating them as post-launch improvements.

Halal status is not a universal substitute for the factory Izin. Screen the finished good, processing aids, lotions, fragrances, adhesives, inks, packaging claims, intended market, and the applicable BPJPH implementation schedule. If certification or a halal claim is pursued, purchasing and traceability systems need to control inputs and suppliers. If it is not applicable, the basis should be documented rather than assumed from the word “paper.” The same discipline applies to product safety testing and consumer labelling.

Industrial reporting begins before the first sales invoice. The current OSS obligations for the core 17091 scope include periodic, validated Industry Data, shown on a six-month basis, along with safety, quality-control, calibration or testing, emergency procedures, and management-system conditions. Use the Ministry of Industry’s SIINas portal as the operational reporting channel where required. A PT PMA must also maintain its investment-activity reporting under the current BKPM procedure. Machine values, installed capacity, employment, utilities, output, investment realisation, and commercial-production dates should reconcile across finance, customs, OSS, SIINas, and investment reports.

Commissioning evidence should be planned during procurement. Retain machine contracts and serial numbers, import and tax records, installation acceptance, safety inspections, operator training, material and product specifications, lab methods, trial results, utility commissioning, wastewater and emission performance, waste handover agreements, emergency drills, calibration records, quality procedures, technical-person appointments, building completion documents, and photographs tied to the approved layout. Verification is much faster when those records exist as an indexed dossier.

Separate the real cost layers

There is no credible single “Indonesia tissue factory licence price.” A useful budget separates amounts that sit on different legal and commercial bases. The IDR 2.5 billion paid-up-capital minimum is company equity. The investment plan of more than IDR 10 billion excluding land and buildings is a project-size rule, assessed under the applicable manufacturing formulation. Neither is a professional fee or government charge. Equipment cost depends on furnish, basis weight, width, speed, automation, converting formats, utilities, local content, freight, duties, installation, and performance guarantees; it should come from line-specific vendor quotations, not an online incorporation package.

For initial planning, an anonymous cross-check of three independent Indonesian corporate-service quotations current in 2026 supports a broad professional-fee allowance of approximately IDR 25 million to IDR 75 million for PT PMA incorporation and baseline corporate or OSS administration. The quotes are not perfectly like-for-like: lower packages commonly exclude translations, complex shareholder documents, address services, licence verification, tax or bank support, and post-incorporation changes. This range is therefore a procurement envelope, not a statutory tariff, a promise of final price, or the cost of licensing a high-risk factory.

Ask bidders to price the same responsibility matrix. A formation proposal should say whether it includes deed and approvals, tax registration, NIB creation, KBLI or scope advice, beneficial-owner filing, translations, address, bank assistance, and post-issue corrections. A factory-licensing proposal should separately identify spatial, environmental, building, sectoral Izin verification, product permissions, testing, and reporting setup. Government or estate charges should be passed through with receipts rather than hidden inside one uncheckable total.

For machinery, issue a common request for quotation. State finished products, composition, basis weight, ply, sheet or roll dimensions, embossing, lamination, printing, packing formats, line speed, uptime, waste guarantee, power, steam, air, water, operators, spares, training, acceptance tests, Incoterms, duties, local installation, and warranty. Compare total installed and commissioned cost, not the machine’s ex-works sticker price. Include building reinforcement, transformer, compressor, dust extraction, fire protection, boiler, water treatment, laboratory, wastewater plant, warehouse racking, forklifts, and spare parts where the scope requires them.

Working capital often becomes the hidden constraint. Model raw-material safety stock, imported lead times, packaging minimum orders, payroll, utilities, maintenance consumables, trial losses, finished-goods inventory, customer credit, and tax timing. Keep a separate regulatory contingency for redesign or retesting; do not use the paid-up-capital minimum as if it were automatically sufficient operating cash.

Sequence setup, construction, and commissioning

A tissue project should be managed as dependent gates, not a list of parallel form submissions. Several tasks can overlap, but a later commitment should not outrun the evidence produced by an earlier gate.

1. Freeze the commercial product universe. Record paper or textile composition, intended use, claims, target capacity, domestic and export markets, and whether the project makes tissue paper, converts purchased parent rolls, or does both.
2. Confirm the classification memorandum. Match every production line to KBLI 17091’s correct OSS scope, identify any truly separate activity, and align the deed description, project name, and capacity units.
3. Approve the investment structure. Set shareholders, governance, paid-up capital, qualifying investment plan, funding path, entity boundaries, and responsible executives. Form the PT PMA and complete tax, beneficial-owner, and bank mobilisation.
4. Screen candidate properties. Test industrial-estate status, KKPR route, utilities, environmental feasibility, PBG and SLF position, fire and access constraints, and expansion. Use conditional lease terms tied to the red-flag report.
5. Build the OSS and basic-requirement file. Obtain the NIB for the correct project and scope, complete spatial and environmental routes, and prepare building approvals. Preserve the current risk-row evidence.
6. Complete detailed engineering and sectoral evidence. Finalise process flow, equipment, safety systems, utility balances, waste controls, organisation, product specifications, responsible technical personnel where applicable, and the verification dossier for the Izin or Standard Certificate.
7. Construct and install under controlled change. Do not move stacks, wastewater units, chemical stores, fire systems, or production capacity away from approved documents without checking amendment consequences.
8. Commission with records. Test utilities, safety interlocks, environmental controls, product quality, calibration, traceability, emergency response, and operator competence. Complete PBG-related closeout and obtain the SLF where applicable.
9. Verify before commercial operation. Confirm the high-risk Izin or medium-high Standard Certificate is issued and verified for the selected scope, complete triggered product permissions, activate reporting, and obtain management sign-off against the licence register.

The critical path cannot be estimated responsibly from incorporation alone. An existing compliant converter building with sufficient power and no process wastewater can move differently from a greenfield integrated mill needing a boiler, water source, wastewater treatment, emission controls, and major PBG work. Use milestone dates with stated assumptions: classification approved, site cleared, environmental route accepted, detailed design frozen, equipment released, construction authorised, utilities ready, verification submitted, product permissions complete, and commercial operation authorised.

Changes must return to the decision tree. Adding wet wipes, lotions, textile-based absorbent goods, printing, a boiler, a second production line, higher capacity, or a new location may alter classification, OSS scope, environment, building, product, customs, and investment records. A formal change-control meeting is cheaper than discovering during inspection that the factory being operated is not the factory described in its approvals.

Use a documented go or no-go test

Approve final investment only when management can answer “yes” to the following evidence-based tests:

• The signed product and process schedule clearly separates paper tissue, textile absorbent goods, and any upstream or ancillary activity.
• Each line is mapped to the correct KBLI 17091 OSS scope, risk rating, large-enterprise output, authority, and verification status.
• The PT PMA ownership, deed, more-than-IDR-10-billion qualifying investment plan, and at-least-IDR-2.5-billion paid-up capital are funded and internally consistent.
• The selected property has a defensible industrial-location and spatial path, confirmed utilities, viable environmental route, and workable PBG and SLF plan.
• Water, wastewater, emissions, paper waste, hazardous waste, fire load, and occupational risks have engineered controls and accountable budgets.
• Every proposed product claim and intended use has been screened for SNI, household-health, health, halal, labelling, testing, and other PB UMKU consequences without applying them indiscriminately.
• Vendor RFQs cover total installed and commissioned equipment cost, and working capital supports the ramp-up and customer cash cycle.
• The company has a commissioning dossier, verified Izin or Standard Certificate as applicable, product permissions, SLF where required, and active SIINas and investment-reporting controls before commercial output.

A “no” is not necessarily a rejected project; it is a condition precedent with an owner, evidence requirement, cost, and deadline. The dangerous outcome is a silent assumption embedded in a land deposit or machine order. An independent tissue factory licensing and site review can turn the product list into a coordinated PT PMA, OSS, property, environmental, building, and commissioning work plan before capital becomes difficult to redirect.